Mergers & Acquisitions Mergers & Acquisitions

Comment: AbbVie-Allergan deal awaits decision in final US FTC phase that takes weeks

By Jenna Ebersole
  • 06 Apr 2020 16:10
  • 06 Apr 2020 16:10
AbbVie and Allergan’s March announcement that they signed a consent decree agreement with US Federal Trade Commission staff was a major step forward for their merger, but the process to a final vote can still take a month or even longer.
The companies said March 17 that they had reached

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News